128 results on '"Schroers, Roland"'
Search Results
2. Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis
3. Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
4. Liquid biopsy based HER2 amplification status in gastric cancer patients indicates clinical response
5. Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
6. GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany
7. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
8. Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
9. Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma.
10. Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.
11. Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
12. HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
13. Novel NUP98::ASH1L Gene Fusion in Acute Myeloid Leukemia Detected by Optical Genome Mapping.
14. Liquid biopsy can cure early colorectal cancer recurrence – Case Report.
15. Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
16. Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome
17. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
18. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
19. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients - data files
20. Successful chimeric antigen receptor (CAR) T-cell treatment in aggressive lymphoma despite coronavirus disease 2019 (CoVID-19) and prolonged severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) replication
21. Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report
22. Patients with primary central nervous system lymphoma not eligible for clinical trials
23. Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel GATA2 Variant
24. Case Report: Hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel \(\it GATA2\) variant
25. Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
26. Pelger-Huët anomaly and T-cell lymphoma
27. High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity.
28. Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
29. Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS
30. Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
31. Digital-droplet PCR for quantification of CD19-directed CAR T-cells
32. Refractory Epstein-Barr Virus (EBV)-related post-transplant lymphoproliferative disease
33. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
34. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen
35. Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
36. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs
37. value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
38. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
39. Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis
40. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma
41. HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series.
42. P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA.
43. Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)
44. Rare finding in peripheral nerve surgery: an unicentric Castleman disease presenting as median nerve tumour.
45. Hemophagocytic Lymphohistiocytosis in Adults (aHLH): Results from the German HLH Registry
46. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
47. High Dose-Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation for Patients with Refractory or Recurrent Primary Central Nervous System Lymphoma –Results of a Multicenter Study By the Germany Collaborative PCNSL Study Group
48. Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?
49. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
50. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.